| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $0.00 | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $5.89M | $21.30M | $11.17M | $9.36M | $5.26M |
| R&D | – | – | – | – | – |
| SG&A | $2.81M | $2.67M | $2.83M | $5.21M | $3.11M |
| Operating Income | – | – | – | – | – |
| Interest Expense | – | – | $29.00K | $39.00K | $25.00K |
| Tax Expense | – | – | – | – | – |
| Net Income | -$4.90M | -$18.45M | -$9.00M | -$9.43M | -$5.40M |
| EPS (basic) | -0.0100 | -0.0400 | -0.0400 | -0.0400 | -0.0300 |
| EPS (diluted) | -0.0100 | -0.0400 | -0.0400 | -0.0400 | -0.0300 |
| Shares (diluted) | $516.13M | $498.14M | $212.69M | $212.48M | $173.49M |